Status In progress
Process STA
ID number 1048

Provisional Schedule

Appraisal consultation 03 April 2018 - 24 April 2018
Committee meeting: 2 10 May 2018
Expected publication 01 August 2018

Project Team

Project lead Jeremy Powell

Email enquiries

Consultees

Companies sponsors Sanofi
Others Department of Health and Social Care
  NHS England
  Welsh Government
Professional groups British Association of Dermatologists
  British Dermatological Nursing Group
  Royal College of Physicians

Commentators

Comparator companies Actavis UK (azathioprine) – not participating
  Aspen (azathioprine)
  Dexcel-Pharma Limited (ciclosporin) – not participating
  Novartis Pharmaceuticals (ciclosporin)
  Sandoz (azathioprine) - not participating
  Santen UK (ciclosporin) - not participating
General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Welsh Health Specialised Services Committee
Relevant research groups UK Dermatology Clinical Trials Network

Timeline

Key events during the development of the guidance:

Date Update
06 March 2018 Committee meeting: 1
02 October 2017 Invitation to participate
10 August 2017 In progress, In progress
26 July 2017 Referral
20 January 2017 Draft scope documents

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance